CME: Opioid Use Disorder: Expanding Access to Treatment

Opioid Use Disorder: Expanding Access to Treatment

Opioid Use Disorder: Expanding Access to Treatment

Skyrocketing overdoses demonstrate the need for providers to not only understand more about opioids, but also to offer meaningful treatments.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Opioid use disorder is a growing problem in the United States.  Every day we hear about the rampant increase in the misuse of prescription analgesics, the easy accessibility of opioids, and the skyrocketing opioid overdoses that demonstrate the need for healthcare providers to not only understand more about these drugs, but also offer meaningful treatments.  

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Matt Birnholz, MD
    Medical Director
    Chicago, IL

    Matt Birnholz, MD has nothing to disclose.  

    Joshua D. Lee, MD
    Associate Professor
    NYU Langone Health
    New York, NY

    Dr. Lee has no financial relationships to disclose.


    • Sean T. Barrett has nothing to disclose.
    • Kenyatta Crenshaw has nothing to disclose.
    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • David Lui has nothing to disclose.
    • Todd W. Mandell, MD has nothing to disclose.
    • Jessica McGrory has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose.
    • Mimi Secor, DNP, FNP-BC, NCMP, FAANP is a speaker for Duchesnay and VIVA.
  • Learning Objectives

    The goal of this activity is to enable effective collaboration between the members of the professional teams who care for patients with OUD.  After participating in this educational activity, participants should be better able to:

    • Examine the need to expand the use of medications to treat opioid use disorder and evaluate existing strategies to achieve that goal
    • Describe the process to safely initiate a patient on XR-Naltrexone
    • Summarize the findings from the X:BOT study and implications for practice  
  • Target Audience

    This activity is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, other nurses, pharmacists, social workers, and any healthcare provider who cares for patients affected by opioid use, dependency, or abuse. 

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Omnia-Prova Education Collaborative (TOPEC) and National Institute on Drug Abuse (NIDA). TOPEC is accredited by the ACCME to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Prova Education designs educational activities based on evidence-based medicine, needs and gaps analyses, learner feedback, and more. Its mission is to serve as an innovative and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

    ReachMD Healthcare Image

  • Commercial Support

    This activity has received no commercial support.  Funding has been provided by the joint provider, National Institute for Drug Abuse.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments


We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free